Document is current
Any future updates will be listed below
-
Authors
Johri, Amer M. https://orcid.org/0000-0001-7044-8212
Hétu, Marie-France
Heyland, Daren K.
Herr, Julia E.
Korol, Jennifer
Froese, Shawna
Norman, Patrick A.
Day, Andrew G.
Matangi, Murray F.
Michos, Erin D.
LaHaye, Stephen A.
Saunders, Fraser W.
Spence, J. David
-
Funding
Funding for this research was provided by:
Heart and Stroke Foundation of Canada (G-14-0005706, Phase I Career #7500)
Southeastern Ontario Academic Medical Organization (Clinician Award)
Queen's University (DOM)
- License Information
-
More Information
Article History
Received: 19 November 2021
Accepted: 22 March 2022
First Online: 2 April 2022
Declarations
:
: Queen’s University Health Sciences and Affiliated Hospitals Research Ethics Board and the Western University Health Sciences Research Ethics Board approved this study. Written informed consent was obtained from all participants. L-carnitine is widely available as an over the counter health food supplement, however Health Canada approval was obtained for off label use of the supplement in MetS. The clinical investigation was conducted according to the Declaration of Helsinki principles.
: No individual data is included in the manuscript (no identifiable information).
: The authors declare that they have no competing interests.
